Add Yahoo as a preferred source to see more of our stories on Google. Lucence founder and CEO Dr. Min-Han Tan (Photo: Enterprise Singapore) Lucence Diagnostics, a genomic medicine startup that ...

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. Novel high-speed microfluidic screening platform could provide comprehensive insight into circulating tumor cells ...

GENOMIC medicine firm Lucence Diagnostics on Wednesday announced it has closed a US$20 million Series A funding round led by mainboard-listed IHH Healthcare, one of the world's largest private ...

SINGAPORE - Local genomic medicine company Lucence announced on Wednesday (Nov 20) that it has received US$20 million (S$27.23 million) in initial funding after it invented a non-invasive test for ...

Lucence Diagnostics, a genomic medicine startup that develops non-invasive tests for cancer screening, announced today that it has raised a $20 million Series A led by IHH Healthcare, one of the world ...